Literature DB >> 12224801

Civilian-based posttraumatic stress disorder and physical complaints: evaluation of depression as a mediator.

Robert Miranda1, Lori A Meyerson, Brian P Marx, Phebe M Tucker.   

Abstract

This study examined the role of comorbid depression in the somatic complaints of 32 individuals with civilian-based posttraumatic stress disorder (PTSD) while restricting the influence of detectable pathophysiology and additional psychiatric conditions. It was hypothesized that depressive symptomatology would mediate the relationship between PTSD and somatic symptom reporting. Participants were administered structured clinical interviews, a physical examination, and an electrocardiogram. Results of this study supported the hypothesis that depressive symptoms mediate the relationship between PTSD and physical complaints. These results add to a growing body of literature that suggests psychological factors play an influential role in the physical symptom reports of individuals with PTSD.

Entities:  

Mesh:

Year:  2002        PMID: 12224801     DOI: 10.1023/A:1016299711568

Source DB:  PubMed          Journal:  J Trauma Stress        ISSN: 0894-9867


  4 in total

Review 1.  [PTSD and chronic pain: development, maintenance and comorbidity--a review].

Authors:  A Liedl; C Knaevelsrud
Journal:  Schmerz       Date:  2008-12       Impact factor: 1.107

2.  Mental health outcomes of Mexico's drug war in Ciudad Juárez: A pilot study among university students.

Authors:  Kathleen O'Connor; Maricarmen Vizcaino; Nora A Benavides
Journal:  Traumatology (Tallahass Fla)       Date:  2014-03-01

3.  The relationships between posttraumatic stress disorder severity, depression severity and physical health.

Authors:  Nina K Rytwinski; Jennifer S Avena; Aileen M Echiverri-Cohen; Lori A Zoellner; Norah C Feeny
Journal:  J Health Psychol       Date:  2013-02-28

4.  Trauma and Pain in Family-Orientated Societies.

Authors:  Jan Ilhan Kizilhan
Journal:  Int J Environ Res Public Health       Date:  2017-12-28       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.